Concerned about your
HIGH BLOOD PRESSURE?

See if the RADIANCE-HTN Study is right for you

Hypertension, or high blood pressure, affects over 1 billion people. Left untreated, high blood pressure can increase your risk of serious health problems such as heart attack, stroke, and kidney failure. Yet nearly 1 in 3 individuals with hypertension struggle to control their blood pressure despite being on medication.

If you’ve been unable to control your blood pressure, or are interested in an alternative to daily medications, you may be a candidate for the RADIANCE-HTN Clinical Study. The study is evaluating a minimally-invasive, catheter-based procedure (the Paradise® Renal Denervation System) which may lower your blood pressure and reduce your need for blood pressure medications.

About the Study

What Causes High Blood Pressure?

Blood pressure is the force of blood against your artery walls as it circulates through your body. Blood pressure naturally rises and falls throughout the day, but it can cause problems if it stays too high for a long time.

Blood pressure is controlled by a complex interaction of signaling from several systems within the body including the nervous system, circulatory system, and endocrine (hormonal) systems. The nerves running to the kidneys are especially important in the control of blood pressure. People with high blood pressure typically have overactive renal (kidney) nerves. It has been shown that calming these overactive nerves can help reduce blood pressure.

What is the Paradise® Renal Denervation System?

The Paradise Renal Denervation system is designed to lower blood pressure by reducing over-activity of kidney nerves through a minimally-invasive procedure. A single, small incision is made in the groin. A small flexible catheter is inserted, and then placed in the artery supplying the kidney. Ultrasound energy (sound waves) is delivered to the tissue surrounding the artery for a few seconds. The ultrasound energy generates heat to decrease the over-activity of the nerves leading to the kidneys. Both kidneys are treated, and the device is then removed.

What is the RADIANCE-HTN Clinical Study?

Right now, doctors at select centers in the US, UK, Netherlands, France, and Germany are conducting a new research study to evaluate the ability of the Paradise Renal Denervation System to lower blood pressure (the RADIANCE-HTN Clinical Study). If you’ve been unable to control your blood pressure, or are interested in an alternative to daily medications, this study may be right for you.

Why Participate?

The Paradise Renal Denervation System may help reduce blood pressure without the need for medications. However, participants in the RADIANCE-HTN Study may also benefit from having their blood pressure condition closely monitored throughout the course of the study. In addition, study participants may receive evaluation of their renal (kidney) anatomy, which may help uncover previously undiagnosed abnormalities or narrowing of the renal artery. Lastly, the results of this study may help other people with high blood pressure in the future.



Frequent Questions
Clinical studies (also called clinical trials) are used to learn about the safety and effectiveness of possible new medications, medical devices, and medical procedures. Although there are many types of clinical trials, all must conform to strict rules set by local regulatory authorities. These rules help protect the rights and safety of those who volunteer to take part in clinical trials.
Renal denervation is a minimally-invasive, catheter-based procedure designed to reduce blood pressure without medications. People with high blood pressure typically have overactive renal (kidney) nerves, and it has been shown that calming these overactive nerves can help reduce blood pressure. The Paradise Renal Denervation system is an investigational device that uses ultrasound energy (sound waves) to decrease over-activity of these nerves.
If you choose to join the study, you will receive all study-related care at no cost. This includes the Paradise Renal Denervation System and procedure, as well as any follow-up visits to your study doctor’s office. You will also be reimbursed for your time and travel to attend these study visits.
If you join the RADIANCE-HTN Clinical Study, your participation will last approximately 3 years. Following your procedure, you will return to your study doctor’s office for 7 follow-up visits over the first year, and will then return for 2 additional annual visits. These visits are an important part of the study, as they allow your study doctor to closely monitor your individual results and experiences.
As with all clinical studies, your participation is completely voluntary, and you may leave the study at any time without any effect on your future medical care.
The study is being sponsored by ReCor Medical, Inc. (www.recormedical.com), a global medical device company with offices in the US and Europe.
To see if you might qualify for the RADIANCE-HTN Clinical Study, and to be referred to a study center in your area, the next step is taking the pre-screening questionnaire. Please click here to get started.

See If You Qualify

To see if you might qualify for the RADIANCE-HTN Clinical Study, and to get connected directly with your local study center to learn more, please take the questionnaire below. If you prefer to take the questionnaire over the phone, please call 1-888-978-8396.